KR20040029021A - 활성성분으로서 펜타닐을 함유하는 경피치료 시스템 - Google Patents
활성성분으로서 펜타닐을 함유하는 경피치료 시스템 Download PDFInfo
- Publication number
- KR20040029021A KR20040029021A KR10-2004-7002709A KR20047002709A KR20040029021A KR 20040029021 A KR20040029021 A KR 20040029021A KR 20047002709 A KR20047002709 A KR 20047002709A KR 20040029021 A KR20040029021 A KR 20040029021A
- Authority
- KR
- South Korea
- Prior art keywords
- active material
- transdermal therapeutic
- fentanyl
- therapeutic system
- microreservoir
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Description
Claims (15)
- 활성물질 불투과성 지지층, 활성물질층, 펜타닐(fentanyl) 및/또는 펜타닐 유사 유도체 및/또는 펜타닐 염 및/또는 펜타닐 유사 유도체의 염인 활성물질, 및 사용하기 전에 제거될 필요가 있는 보호층을 포함하며, 이때 상기 활성물질층이 그 안에 분산된 마이크로저장소를 갖는 중합체를 포함함을 특징으로 하는 경피치료 시스템(TTS).
- 제 1 항에 있어서,중합체가 압력에 민감한 점착성 중합체임을 특징으로 하는 경피치료 시스템.
- 제 1 항 또는 제 2 항에 있어서,중합체가 아민에 저항성이 있는 폴리실록산임을 특징으로 하는 경피치료 시스템.
- 제 1 항 내지 제 3 항 중 어느 한 항에 있어서,마이크로저장소가 액체를 포함함을 특징으로 하는 경피치료 시스템.
- 제 1 항 내지 제 4 항 중 어느 한 항에 있어서,활성물질이 마이크로저장소 내에 완전히 용해된 상태로 존재함을 특징으로 하는 경피치료 시스템.
- 제 1 항 내지 제 5 항 중 어느 한 항에 있어서,경피치료 시스템 중의 활성물질의 최소한 50%가 마이크로저장소 내에 함유됨을 특징으로 하는 경피치료 시스템.
- 제 1 항 내지 제 6 항 중 어느 한 항에 있어서,액체가 디프로필렌 글리콜, 디에틸렌 글리콜 모노에틸 에테르, 디에틸렌 글리콜 디에틸 에테르, 디에틸렌 글리콜 모노메틸 에테르, 디에틸렌 글리콜 디메틸 에테르, 1,3-부탄디올, 2,2-디메틸-4-하이드록시메틸-1,3-디옥솔란, 2-피롤리돈 또는 N-메틸피롤리돈 또는 그 조합을 포함함을 특징으로 하는 경피치료 시스템.
- 제 1 항 내지 제 7 항 중 어느 한 항에 있어서,액체가 점도를 증가시키는 첨가제, 바람직하게는 에틸셀룰로오즈 또는 하이드록시프로필셀룰로오즈를 포함함을 특징으로 하는 경피치료 시스템.
- 제 1 항 내지 제 8 항 중 어느 한 항에 있어서,활성물질층 내에서 활성물질의 농도가 5 중량% 이하, 바람직하게는 4 중량%이하임을 특징으로 하는 경피치료 시스템.
- 제 1 항 내지 제 9 항 중 어느 한 항에 있어서,단위 면적당 활성물질층의 중량이 30 내지 300g/㎡ 사이임을 특징으로 하는 경피치료 시스템.
- 제 1 항 내지 제 10 항 중 어느 한 항에 있어서,멤브레인 및, 적당한 경우, 점착성층을 포함함을 특징으로 하는 경피치료 시스템.
- 제 11 항에 있어서,멤브레인이 에틸렌-비닐 아세테이트 공중합체 또는 폴리에틸렌 또는 폴리프로필렌에 기초한 미세다공성 필름을 포함함을 특징으로 하는 경피치료 시스템.
- 제 12 항에 있어서,에틸렌-비닐 아세테이트 공중합체가 2 내지 25% 비닐 아세테이트 함량 및 20 내지 150㎛ 사이의 두께를 가지는 것을 특징으로 하는 경피치료 시스템.
- 제 1 항 내지 제 13 항 중 어느 한 항에 있어서,활성물질층이 인간 피부를 통한 침투속도를 증진시키는 물질을 추가로 포함함을 특징으로 하는 경피치료 시스템.
- 제 14 항에 있어서,활성물질이 지방산, 지방산 에스테르, 지방 알콜, 및 글리세롤 에스테르로 구성된그룹에 속하는 것을 특징으로 하는 경피치료 시스템.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10141651.2 | 2001-08-24 | ||
DE10141651A DE10141651B4 (de) | 2001-08-24 | 2001-08-24 | Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung |
PCT/EP2002/007663 WO2003018071A1 (de) | 2001-08-24 | 2002-07-10 | Transdermales therapeutisches system (tts) mit dem wirkstoff fentanyl |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040029021A true KR20040029021A (ko) | 2004-04-03 |
KR100895188B1 KR100895188B1 (ko) | 2009-04-24 |
Family
ID=7696569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020047002709A KR100895188B1 (ko) | 2001-08-24 | 2002-07-10 | 활성성분으로서 펜타닐을 함유하는 경피치료 시스템 |
Country Status (24)
Country | Link |
---|---|
US (2) | US7390500B2 (ko) |
EP (1) | EP1418951B1 (ko) |
JP (1) | JP4628673B2 (ko) |
KR (1) | KR100895188B1 (ko) |
CN (1) | CN100438859C (ko) |
AT (1) | ATE455541T1 (ko) |
AU (1) | AU2002321199B2 (ko) |
BR (1) | BRPI0212028B8 (ko) |
CA (1) | CA2457245C (ko) |
CY (1) | CY1109954T1 (ko) |
DE (2) | DE10141651B4 (ko) |
DK (1) | DK1418951T3 (ko) |
ES (1) | ES2339640T3 (ko) |
HK (1) | HK1069534A1 (ko) |
HU (1) | HU229942B1 (ko) |
IL (2) | IL160515A0 (ko) |
MX (1) | MXPA04001679A (ko) |
NZ (1) | NZ530795A (ko) |
PL (1) | PL204348B1 (ko) |
PT (1) | PT1418951E (ko) |
RU (1) | RU2311908C2 (ko) |
TW (1) | TW570815B (ko) |
WO (1) | WO2003018071A1 (ko) |
ZA (1) | ZA200400473B (ko) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10141650C1 (de) * | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
US20040086551A1 (en) | 2002-10-30 | 2004-05-06 | Miller Kenneth J. | Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl |
RU2348397C2 (ru) * | 2003-02-07 | 2009-03-10 | Лтс Ломанн Терапи-Системе Аг | Трансдермальная терапевтическая система, пригодная для использования тепла с целью ускорения проникновения биологически активных веществ, и ее применение |
PL219512B1 (pl) * | 2003-04-14 | 2015-05-29 | Lohmann Therapie Syst Lts | Plaster miejscowy, zastosowanie plastra miejscowego i sposób wytwarzania plastra miejscowego |
US20110086086A1 (en) * | 2005-07-26 | 2011-04-14 | Pfizer Inc | Transdermal system for varenicline |
DE102006019293A1 (de) * | 2006-04-21 | 2007-10-25 | LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH | Pflaster, enthaltend ein Fentanyl Analogum |
GB0615429D0 (en) * | 2006-08-03 | 2006-09-13 | Chowdhury Dewan F H | Transdermal drug delivery with temporal control |
DE102006054731B4 (de) | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie |
DE102006054732B4 (de) * | 2006-11-21 | 2010-12-30 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren |
DE102008016804B4 (de) * | 2008-04-02 | 2012-01-05 | Lts Lohmann Therapie-Systeme Ag | Selbstzerstörendes transdermales therapeutisches System mit verbesserter Funktionalität und Wirksamkeit sowie seine Verwendung |
US20100221313A1 (en) * | 2008-12-01 | 2010-09-02 | Innovative Pharmaceuticals, Llc | Transdermal reservoir patch |
IN2012DN00845A (ko) * | 2009-07-21 | 2015-06-26 | Mylan Inc | |
US9822088B2 (en) | 2011-03-30 | 2017-11-21 | The United States Of America As Represented By The Administrator Of Nasa | Anisotropic copoly(imide oxetane) coatings and articles of manufacture, copoly(imide oxetane)s containing pendant fluorocarbon moieties, oligomers and processes therefor |
DE102011080390B3 (de) * | 2011-08-03 | 2012-07-12 | Acino Ag | Applikationshilfe |
TW201338813A (zh) | 2011-12-12 | 2013-10-01 | Lohmann Therapie Syst Lts | 經皮遞送系統 |
TW201431570A (zh) * | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀(Rotigotine)之多天式貼片 |
JP6559121B2 (ja) | 2013-06-04 | 2019-08-14 | エルテーエス ローマン テラピー−ジステーメ アーゲー | 経皮送達システム |
CA2916183C (en) | 2013-07-03 | 2022-03-29 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system with electronic component |
EP4238580A3 (en) | 2014-05-20 | 2023-10-25 | LTS Lohmann Therapie-Systeme AG | Transdermal delivery system including an interface mediator |
CA2948219C (en) | 2014-05-20 | 2023-04-04 | Lts Lohmann Therapie-Systeme Ag | Method for adjusting the release of active agent in a transdermal delivery system |
CA2948220C (en) | 2014-05-20 | 2023-06-20 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system containing rotigotine |
US9962340B2 (en) | 2015-06-09 | 2018-05-08 | Life Tech Global, Llc | Device and method for the transdermal delivery of cannabidiol |
US10272125B2 (en) * | 2015-09-14 | 2019-04-30 | Life Tech Global, Llc | Transdermal delivery of cannabidiol with other active moieties including cannabinoids |
US9650338B1 (en) | 2016-07-29 | 2017-05-16 | VDM Biochemicals, Inc. | Opioid antagonist compounds and methods of making and using |
DE102017107468B4 (de) | 2017-04-06 | 2019-02-21 | Lts Lohmann Therapie-Systeme Ag | Verfahren zur herstellung eines, insbesondere oralen, wirkstofflaminats und wirkstofflaminat, insbesondere orales wirkstofflaminat |
JP7175913B2 (ja) | 2017-04-18 | 2022-11-21 | ブレイクスルー・テクノロジーズ・エルエルシー | 硫黄生成 |
EP3678646B1 (en) * | 2017-09-04 | 2021-09-29 | LTS Lohmann Therapie-Systeme AG | Transdermal delivery system including an emulsifier |
JP6912122B2 (ja) * | 2019-02-28 | 2021-07-28 | 日本臓器製薬株式会社 | 経皮投与製剤 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5310559A (en) * | 1982-09-01 | 1994-05-10 | Hercon Laboratories Corporation | Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer |
US4588580B2 (en) | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
US4645502A (en) * | 1985-05-03 | 1987-02-24 | Alza Corporation | Transdermal delivery of highly ionized fat insoluble drugs |
US6110488A (en) * | 1986-08-28 | 2000-08-29 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system, its use and production process |
US4906463A (en) * | 1986-12-22 | 1990-03-06 | Cygnus Research Corporation | Transdermal drug-delivery composition |
US4822802A (en) * | 1987-02-24 | 1989-04-18 | Alza Corporation | Method of fentanly administration for postoperative pain relief |
US4849224A (en) * | 1987-11-12 | 1989-07-18 | Theratech Inc. | Device for administering an active agent to the skin or mucosa |
FR2623718B1 (fr) * | 1987-11-27 | 1994-04-15 | Fabre Medicament Pierre | Dispositif therapeutique transdermique et son procede de preparation |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
DE3905051A1 (de) * | 1989-02-18 | 1990-08-30 | Lohmann Therapie Syst Lts | Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (i) |
DE3910543A1 (de) * | 1989-04-01 | 1990-10-11 | Lohmann Therapie Syst Lts | Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung |
SE8904296D0 (sv) * | 1989-12-21 | 1989-12-21 | Pharmacia Ab | Transdermal system |
JP3202777B2 (ja) * | 1992-01-24 | 2001-08-27 | リンテック株式会社 | 経皮吸収促進剤及びテープ製剤 |
JP3489831B2 (ja) * | 1993-04-20 | 2004-01-26 | ヘクサル・アクチエンゲゼルシャフト | 活性成分パッチ |
CN1094972A (zh) * | 1993-05-21 | 1994-11-16 | 深圳广信生物工程公司 | 控释透皮治疗***及其制备与应用 |
JP3240496B2 (ja) * | 1993-09-30 | 2001-12-17 | タキロン株式会社 | 経皮吸収製剤 |
US5665378A (en) * | 1994-09-30 | 1997-09-09 | Davis; Roosevelt | Transdermal therapeutic formulation |
JP4346696B2 (ja) * | 1996-05-28 | 2009-10-21 | 久光製薬株式会社 | 経皮治療用装置 |
DE19728517C2 (de) * | 1997-07-04 | 1999-11-11 | Sanol Arznei Schwarz Gmbh | TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung |
KR19980025307A (ko) * | 1998-04-11 | 1998-07-06 | 조태임 | 진통효과를 갖는 약물의 경피흡수제제 |
US6312715B1 (en) * | 1998-05-01 | 2001-11-06 | 3M Innovative Properties Company | Adhesive microsphere drug delivery composition |
DE19958554C2 (de) * | 1999-07-02 | 2002-06-13 | Lohmann Therapie Syst Lts | Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung |
ES2194736T3 (es) * | 1999-07-02 | 2003-12-01 | Lohmann Therapie Syst Lts | Sistema de microdepositos sobre la base de polisiloxanos y disolvente ambifilos. |
US6893655B2 (en) * | 2001-10-09 | 2005-05-17 | 3M Innovative Properties Co. | Transdermal delivery devices |
-
2001
- 2001-08-24 DE DE10141651A patent/DE10141651B4/de not_active Expired - Lifetime
-
2002
- 2002-07-10 PT PT02754860T patent/PT1418951E/pt unknown
- 2002-07-10 IL IL16051502A patent/IL160515A0/xx unknown
- 2002-07-10 PL PL366857A patent/PL204348B1/pl unknown
- 2002-07-10 AT AT02754860T patent/ATE455541T1/de active
- 2002-07-10 MX MXPA04001679A patent/MXPA04001679A/es active IP Right Grant
- 2002-07-10 JP JP2003522586A patent/JP4628673B2/ja not_active Expired - Lifetime
- 2002-07-10 HU HU0401512A patent/HU229942B1/hu unknown
- 2002-07-10 KR KR1020047002709A patent/KR100895188B1/ko active IP Right Grant
- 2002-07-10 ES ES02754860T patent/ES2339640T3/es not_active Expired - Lifetime
- 2002-07-10 RU RU2004108849/15A patent/RU2311908C2/ru active
- 2002-07-10 CN CNB02816427XA patent/CN100438859C/zh not_active Expired - Lifetime
- 2002-07-10 NZ NZ530795A patent/NZ530795A/en not_active IP Right Cessation
- 2002-07-10 DK DK02754860.1T patent/DK1418951T3/da active
- 2002-07-10 BR BRPI0212028 patent/BRPI0212028B8/pt not_active IP Right Cessation
- 2002-07-10 EP EP02754860A patent/EP1418951B1/de not_active Expired - Lifetime
- 2002-07-10 AU AU2002321199A patent/AU2002321199B2/en not_active Expired
- 2002-07-10 DE DE50214184T patent/DE50214184D1/de not_active Expired - Lifetime
- 2002-07-10 US US10/487,375 patent/US7390500B2/en not_active Expired - Lifetime
- 2002-07-10 CA CA2457245A patent/CA2457245C/en not_active Expired - Lifetime
- 2002-07-10 WO PCT/EP2002/007663 patent/WO2003018071A1/de active IP Right Grant
- 2002-08-22 TW TW091119026A patent/TW570815B/zh not_active IP Right Cessation
-
2004
- 2004-01-22 ZA ZA200400473A patent/ZA200400473B/en unknown
- 2004-02-23 IL IL160515A patent/IL160515A/en active IP Right Grant
-
2005
- 2005-03-11 HK HK05102132.0A patent/HK1069534A1/xx not_active IP Right Cessation
-
2008
- 2008-05-07 US US12/116,303 patent/US20080274167A1/en not_active Abandoned
-
2010
- 2010-03-29 CY CY20101100289T patent/CY1109954T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100895188B1 (ko) | 활성성분으로서 펜타닐을 함유하는 경피치료 시스템 | |
US10709669B2 (en) | Microreservoir system based on polysiloxanes and ambiphilic solvents | |
US10799545B2 (en) | Transdermal delivery of cannabidiol with other active moieties including cannabinoids | |
TWI435737B (zh) | 經皮遞送醫藥化合物的方法及其組成物 | |
KR100483476B1 (ko) | 이중 점착제 경피 약물전달체계 | |
JP5453211B2 (ja) | 不正使用の可能性が低い経皮鎮痛薬システム | |
US4031894A (en) | Bandage for transdermally administering scopolamine to prevent nausea | |
MXPA03008349A (es) | Parche transdermico para administrar fentanilo. | |
KR20120107153A (ko) | 펜타닐 경피 패치제 | |
IL147247A (en) | The mikveh micro-system is based on polysiloxanes and ambiphilic solvents | |
NZ531789A (en) | A medical device from which analgesic drugs are delivered from a drug reservoir controlled by plasticizers and adhesive matrix material | |
KR100624500B1 (ko) | 레리세트론 전달용 경피치료시스템 | |
JP5687901B2 (ja) | 日に1回の取り替えによるフェンタニルの経皮投与 | |
CA2642338A1 (en) | Adhesive preparation comprising sufentanil and methods of using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130412 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140411 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20150416 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20160408 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170407 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20180413 Year of fee payment: 10 |